RE: a bitter pill28 Dec 2017 13:57
Fallingknife1,
There is a great pipeline of products which I expect to generate significant sales in the next few years; however, they are [imo] going to have to raise more funds soon - hopefully it will not be a too high a discount on the prevailing share price at the time. at least the institutional investors here have very deep pockets.
The last major placing was £40m at 10p which funded the acquisition of CellRight - I feel that this has 'brexit-proofed' the company and reduced the risks associated with potentially losing EMA accreditation. Only time will tell.